Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy.
CAT# | R1116 |
CAS | 168650-46-2 |
Synonyms/Alias | Tyrosinase |
M.F/Formula | C₄₂H₆₆N₁₀O₁₆S₂ |
M.W/Mr. | 1031.16 |
Sequence | One Letter Code: YMDGTMSQV three Letter Code: Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val |
Areas of Interest | Antigen-presenting Cells; Cancer Research |
Disease | Melanoma |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The β-amyloid precursor protein (APP) is connected to Alzheimer's disease by both biochemistry and genetics. As ...
BA 1 (DTyr-Gln-Trp-Ala-Val- Ala-His-Phe-Nle-NH2) is a potent BRS-3 agonist (IC50 = 2.52 nM) and a NMBR and GRPR ...
P11 (HSDVHK) is a novel peptide ligand containing a PDZ-binding motif (Ser-Asp-Val) with high affinity to integr ...
PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...
The peptide Difopein, designed, isolated and identified by Haian Fu, is a high affinity inhibitor of 14-3-3 pro ...